How combining novel 3D models and mechanical screening can meet regulatory expectations
A live session for cosmetics researchers | November 12th at 9 AM and 4 PM CET
In this webinar, we will explore how the mechanical characterization of biomimetic 3D microphysiological systems, such as tissue spheroids, enables novel ways of assessing crucial functional properties of tissues, including stiffness, viscoelasticity, and hydration levels. You will learn about Vitroscreen’s ORA® 3D dermis model and its application to anti-aging efficacy based on injectable MD HA-based treatments, and how Optics11 Life’s nanoindentation technology can be leveraged to extract functional, quantitative insight for improved product development.
- Vitroscreen’s ORA® 3D dermis model and its application in evaluating revitalizing and anti-aging treatments
- How the profiling and modulation of mechanical features can work as effective tools to accelerate the market positioning of substance-based medical devices
- Optics11 Life’s nanoindentation technology offers quantitative mechanical insights as an alternative approach to demonstrating product efficacy.
- How spheroid models can recapitulate aging features, working as a more predictive testing platform for pre-clinical in-vitro studies.
- Strategies to align preclinical testing with regulatory expectations, supporting efficacy claims.
Webinar Details
Date: Wednesday, November 12th
Time: 09:00 AM & 16:00 PM CET
Presenter:
Massimiliano Berardi PhD, Optics11 Life
Francesca Rescigno PhD, VitroScreen
Format: Live online webinar with Q&A
Choose your preferred time for the Webinar
Please note that the Webinar has 2 time slots: 09:00 and 16:00. Please use the form that best fits your schedule.
